Real-World 1-Year Outcomes of Treatment-Intensive Neovascular Age-Related Macular Degeneration Switched to Faricimab
Authors:
- Sing Yue SimSSSing Yue Sim
- Evangelia ChalkiadakiECEvangelia Chalkiadaki
- Georgios KoutsocherasGKGeorgios Koutsocheras
- Luke NicholsonLNLuke Nicholson
- Sobha SivaprasadSSSobha Sivaprasad
- Praveen J. PatelPPPraveen J. Patel
- Pearse A. KeanePKPearse A. Keane
- Bhairavi BhatiaBBBhairavi Bhatia
- Robin HamiltonRHRobin Hamilton
- Abison LogeswaranALAbison Logeswaran
Top Cited Papers
- 30 July 2024
- journal article
- research article
- Published by Elsevier in Ophthalmology Retina
- Vol. 9 (1) , 22-30
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trialsThe Lancet, 2022
- Tachyphylaxis during treatment of exudative age-related macular degeneration with afliberceptGraefe's Archive for Clinical and Experimental Ophthalmology, 2019
- Three-Year Outcomes of Aflibercept Treatment for Neovascular Age-Related Macular Degeneration: Evidence from a Clinical SettingOphthalmology and Therapy, 2018
- Global causes of blindness and distance vision impairment 1990–2020: a systematic review and meta-analysisThe Lancet Global Health, 2017
- Long-term Safety and Visual Outcome of Intravitreal Aflibercept in Neovascular Age-Related Macular DegenerationOphthalmology Retina, 2017
- Five-Year Outcomes with Anti–Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular DegenerationOphthalmology, 2016
- Risk of Scar in the Comparison of Age-related Macular Degeneration Treatments TrialsOphthalmology, 2014
- Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular DegenerationOphthalmology, 2012
- HORIZON: An Open-Label Extension Trial of Ranibizumab for Choroidal Neovascularization Secondary to Age-Related Macular DegenerationOphthalmology, 2012
- Incidence of Legal Blindness From Age-Related Macular Degeneration in Denmark: Year 2000 to 2010American Journal of Ophthalmology, 2012